Anavex Life Sciences Corp (AVXL)

[Investor2014]

Listened and was glad to hear Misslings PM description.

He is not saying that the WT vs variant Sigma-1 gene findings are to select patients thereby increasing chance of success. Instead the highly stat sig finding is another clear confirmation that the Sigma-1 MOA target is activated for efficacy by a2-73.

This along with the RNA expression confirmation adds some weight against the concern that the study was not placebo controlled.